专家论坛｜尹明：HBV感染的动物模型研究进展( 六 )

[9]RYBICKA M, BIELAWSKI KP. Recent advances in understanding, diagnosing, and treating hepatitis B virus infection[J]. Microorganisms, 2020, 8(9): 1416. DOI: 10.3390/microorganisms8091416.
[10]BABINET C, FARZA H, MORELLO D, et al. Specific expression of hepatitis B surface antigen (HBsAg) in transgenic mice[J]. Science, 1985, 230(4730): 1160-1163. DOI: 10.1126/science.3865370.
[11]BURK RD, DELOIA JA, ELAWADY MK, et al. Tissue preferential expression of the hepatitis B virus (HBV) surface antigen gene in two lines of HBV transgenic mice[J]. J Virol, 1988, 62(2): 649-654. DOI: 10.1128/JVI.62.2.649-654.1988.
[12]CHISARI FV, PINKERT CA, MILICH DR, et al. A transgenic mouse model of the chronic hepatitis B surface antigen carrier state[J]. Science, 1985, 230: 1157-1160. DOI: 10.1126/science.3865369.
[13]GUIDOTTI LG, MARTINEZ V, LOH YT, et al. Hepatitis B virus nucleocapsid particles do not cross the hepatocyte nuclear membrane in transgenic mice[J]. J Virol, 1994, 68(9): 5469-5475. DOI: 10.1128/JVI.68.9.5469-5475.1994.
[14]MILICH DR, JONES JE, HUGHES JL, et al. Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero?[J]. Proc Natl Acad Sci U S A, 1990, 87(17): 6599-6603. DOI: 10.1073/pnas.87.17.6599.
[15]KIM CM, KOIKE K, SAITO I, et al. HBx gene of hepatitis B virus induces liver cancer in transgenic mice[J]. Nature, 1991, 351(6324): 317-320. DOI: 10.1038/351317a0.
[16]LEE TH, FINEGOLD MJ, SHEN RF, et al. Hepatitis B virus transactivator X protein is not tumorigenic in transgenic mice[J]. J Virol, 1990, 64(12): 5939-5947. DOI: 10.1128/JVI.64.12.5939-5947.1990.
[17]ARAKI K, MIYAZAKI J, HINO O, et al. Expression and replication of hepatitis B virus genome in transgenic mice[J]. Proc Natl Acad Sci U S A, 1989, 86(1): 207-211. DOI: 10.1073/pnas.86.1.207.
[18]FARZA H, HADCHOUEL M, SCOTTO J, et al. Replication and gene expression of hepatitis B virus in a transgenic mouse that contains the complete viral genome[J]. J Virol, 1988, 62(11): 4144-4152. DOI: 10.1128/JVI.62.11.4144-4152.1988.
[19]GUIDOTTI LG, MATZKE B, SCHALLER H, et al. High-level hepatitis B virus replication in transgenic mice[J]. J Virol, 1995, 69(10): 6158-6169. DOI: 10.1128/JVI.69.10.6158-6169.
[20]CAVANAUGH VJ, GUIDOTTI LG, CHISARI FV. Interleukin-12 inhibits hepatitis B virus replication in transgenic mice[J]. J Virol, 1997, 71(4): 3236-3243. DOI: 10.1128/JVI.71.4.3236-3243.1997.
[21]ISOGAWA M, ROBEK MD, FURUICHI Y, et al. Toll-like receptor signaling inhibits hepatitis B virus replication in vivo[J]. J Virol, 2005, 79(11): 7269-7272. DOI: 10.1128/JVI.79.11.7269-7272.2005.
[22]UPRICHARD SL, BOYD B, ALTHAGE A, et al. Clearance of hepatitis B virus from the liver of transgenic mice by short hairpin RNAs[J]. Proc Natl Acad Sci U S A, 2005, 102(3): 773-778. DOI: 10.1073/pnas.0409028102.
[23]WINER BY, DING Q, GASKA JM, et al. In vivo models of hepatitis B and C virus infection[J]. FEBS Lett, 2016, 590(13): 1987-1999. DOI: 10.1002/1873-3468.12157.